Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | FAAH | O00519 | 1/20 | 0.50 |
| ▸ | PHGDH | O43175 | 1/20 | 0.50 |
| ▸ | MGLL | Q99685 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL320116 | 0.82 | POLB (0.59) | KMT2APOLBKDM4EFAAHPHGDH | |
| SCHEMBL17704773 | 0.82 | KMT2A (0.53) | KMT2APOLBKDM4EFAAHPHGDH | |
| SCHEMBL455438 | 0.82 | KMT2A (0.53) | KMT2APOLBKDM4EFAAHPHGDH | |
| SCHEMBL208445 | 0.80 | ALDH1A1 (0.54) | KMT2APOLBKDM4EFAAHPHGDH | |
| SCHEMBL14134390 | 0.80 | POLB (0.57) | KMT2APOLBKDM4EFAAHPHGDH | |
| SCHEMBL14134499 | 0.80 | POLB (0.57) | KMT2APOLBKDM4EFAAHPHGDH | |
| Hydrochloric Acid SCHEMBL6788749 | 0.80 | KMT2A (0.52) | KMT2APOLBKDM4EFAAHPHGDH | |
| SCHEMBL14134508 | 0.80 | POLB (0.57) | KMT2APOLBKDM4EFAAHPHGDH | |
| SCHEMBL10457089 | 0.79 | NPC1 (0.53) | KMT2APOLBCA12CA1CA2 | |
| Bicarbonate SCHEMBL7649134 | 0.79 | HPGD (0.64) | KMT2AKDM4ENPSR1HTTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118239868-A | Carbamate substituted styryl sulfone compound and preparation method and application thereof | 华夏生生药业(北京)有限公司 | 2024-06-25 | — | — | CN | claimed |
| EP-4001263-B1 | CARBAMATE-SUBSTITUTED STYRYL SULFONE COMPOUND, PREPARATION METHOD, AND APPLICATION THEREOF | HUAXIASHENGSHENG PHARMACEUTICAL BEIJING CO LTD (CN) | 2024-03-27 | — | — | EP | claimed |
| EP-4001263-A1 | CARBAMATE-SUBSTITUTED STYRYL SULFONE COMPOUND, PREPARATION METHOD, AND APPLICATION THEREOF | Huaxiashengsheng Pharmaceutical Beijing Co., Ltd. (CN) | 2022-05-25 | — | — | EP | claimed |
| CN-114072380-A | Carbamate substituted styryl sulfone compound and preparation method and application thereof | 华夏生生药业(北京)有限公司 | 2022-02-18 | — | — | CN | claimed |
| US-5238909-A | For preemergence or postemergence use | EASTMAN KODAK COMPANY (US) | 1993-08-24 | — | — | US | claimed |
| US-4289693-A | TEXTILES | SANDOZ LTD. (CH) | 1981-09-15 | — | — | US | claimed |
| CN-118239868-A | Carbamate substituted styryl sulfone compound and preparation method and application thereof | 华夏生生药业(北京)有限公司 | 2024-06-25 | — | — | CN | disclosed |
| EP-4001263-B1 | CARBAMATE-SUBSTITUTED STYRYL SULFONE COMPOUND, PREPARATION METHOD, AND APPLICATION THEREOF | HUAXIASHENGSHENG PHARMACEUTICAL BEIJING CO LTD (CN) | 2024-03-27 | — | — | EP | disclosed |
| CN-114072380-B | Carbamate substituted styryl sulfone compound and preparation method and application thereof | 华夏生生药业(北京)有限公司 | 2024-03-15 | — | — | CN | disclosed |
| EP-4001263-A1 | CARBAMATE-SUBSTITUTED STYRYL SULFONE COMPOUND, PREPARATION METHOD, AND APPLICATION THEREOF | Huaxiashengsheng Pharmaceutical Beijing Co., Ltd. (CN) | 2022-05-25 | — | — | EP | disclosed |
| CN-114072380-A | Carbamate substituted styryl sulfone compound and preparation method and application thereof | 华夏生生药业(北京)有限公司 | 2022-02-18 | — | — | CN | disclosed |
| US-20200121652-A1 | COMPOUNDS HAVING CASPASE INHIBITORY ACTIVITY, PHARMACEUTICAL AGENT CONTAINING SAID COMPOUNDS AND FOR TREATING OR PREVENTING CORNEAL ENDOTHELIAL SYMPTOMS, DISORDERS, OR DISEASES, AND APPLICATION OF SAID PHARMACEUTICAL AGENT | THE DOSHISHA (JP) | 2020-04-23 | — | — | US | disclosed |
| EP-3639855-A1 | COMPOUNDS HAVING CASPASE INHIBITORY ACTIVITY, PHARMACEUTICAL AGENT CONTAINING SAID COMPOUNDS AND FOR TREATING OR PREVENTING CORNEAL ENDOTHELIAL SYMPTOMS, DISORDERS, OR DISEASES, AND APPLICATION OF SAID PHARMACEUTICAL AGENT | The Doshisha (JP) | 2020-04-22 | — | — | EP | disclosed |
| EP-1322639-A1 | SUBSTITUTED ARYL KETONES AND THEIR USE AS HERBICIDES | Bayer CropScience AG (DE) | 2003-07-02 | — | — | EP | disclosed |
| WO-2002010155-A1 | SUBSTITUTED ARYL KETONES AND THEIR USE AS HERBICIDES | BAYER CROPSCIENCE AG (DE) | 2002-02-07 | — | — | WO | disclosed |
| WO-1998011070-A1 | PROCESS FOR THE MANUFACTURE OF (2'-FLUOROPHENYL)-3-HALOPYRIDINES | BASF AKTIENGESELLSCHAFT (DE) | 1998-03-19 | — | — | WO | disclosed |
| US-5338658-A | Nucleation agent | FUJI PHOTO FILM CO., LTD. (JP) | 1994-08-16 | — | — | US | disclosed |
| US-5238909-A | For preemergence or postemergence use | EASTMAN KODAK COMPANY (US) | 1993-08-24 | — | — | US | disclosed |
| EP-0349265-A2 | Electroluminescent devices | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1990-01-03 | — | — | EP | disclosed |
| US-4289693-A | TEXTILES | SANDOZ LTD. (CH) | 1981-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200121652-A1 | COMPOUNDS HAVING CASPASE INHIBITORY ACTIVITY, PHARMACEUTICAL AGENT CONTAINING SAID COMPOUNDS AND FOR TREATING OR PREVENTING CORNEAL ENDOTHELIAL SYMPTOMS, DISORDERS, OR DISEASES, AND APPLICATION OF SAID PHARMACEUTICAL AGENT | TGFB1, CASP3, TGFB2 | KMT2A 4777/4885POLB 2513/4885KDM4E 3202/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.